Check out the firms making headlines noon Monday:
AstraZeneca — Shares of British pharmaceutical large AstraZeneca fell more than 3% after the firm stated scientific trials confirmed its coronavirus vaccine has a median efficacy of 70% in stopping the virus. Its opponents Pfizer and Moderna beforehand stated their Covid-19 vaccine candidates have been more than 90% efficient.
Regeneron — Regeneron gained as a lot as 3.9% after the Food and Drug Administration over the weekend granted an emergency use authorization for its antibody therapy REGN-COV2. Regeneron CEO Dr. Leonard Schleifer advised CNBC Monday the firm will present the U.S. with 300,000 doses by early January.
United Airlines, Carnival Corp. — Shares of airways and cruise operators rose broadly amid optimism round a probably robust financial restoration as more vaccine trials present promising outcomes. United Airlines traded increased by 2.6%. Carnival Corp superior 3.7%.
Gap — Shares of the retailer jumped more than 7% after JPMorgan upgraded the inventory to an obese score. The agency stated Old Navy is “benefitting larger picture from the disproportionate growth of ‘value retail,'” whereas Athleta is “well positioned to capitalize on the athletic apparel sector growth.” The agency raised its Dec. 2021 value goal to $30, which is 64% above the inventory’s Friday closing value.
General Motors — Shares of the legacy automaker rose 2.3%, persevering with their rise after GM’s bullish projections about its electrical future final week. If the inventory finishes in constructive territory Monday, it is going to be the fourth-straight constructive session for GM.
Roku — Roku shares popped more than 5% after the company’s value goal was hiked by Needham. The agency raised its 12-month value goal on the inventory to $315 per share from $255 per share. That implies an upside of practically 20% from its Friday closing value. Needham stated Roku “benefits from long-term upside connected TV.”
Foot Locker — Piper Sandler downgraded the retailer to an underweight score, inflicting shares to slip practically 1.5%. The agency stated Foot Locker lacks close to time period visibility as Covid-19 circumstances rise, and that over the long run Nike’s direct-to-consumer efforts may strain the firm.
Tesla — The electrical automobile firm’s inventory continued its current surge on Monday, gaining 5.9%. Wedbush raised its value goal on the inventory to $560 per share from $500, and the agency stated it was optimistic about Tesla’s upcoming Cybertruck and Model Y.
—CNBC’s Pippa Stevens, Yun Li and Jesse Pound contributed to this report.